Abstract: According to an embodiment of the disclosure, a display device may include an active layer, a gate electrode disposed on the active layer, a first insulating layer disposed on the gate electrode, entirely covering the gate electrode, and including a flat surface, and a second insulating layer disposed on the first insulating layer and including a flat surface, and the first insulating layer and the second insulating layer may include inorganic materials different from each other.

Abstract: A cleaning system is provided. The cleaning system includes a robot cleaner and a station. The robot cleaner includes a pad fixing part on which a cleaning pad is detachably mounted, a lifter to lift a part of the robot cleaner at which the pad fixing part is positioned, and a pad detacher to detach the cleaning pad mounted on the pad fixing part. The station includes a pad storage box in which a cleaning pad that is to be provided to the robot cleaner is stored, a pad coupling part on which a cleaning pad that is to be coupled to the robot cleaner is rested, and a pad supplier to supply the cleaning pad stored in the pad storage box to the pad coupling part.

Abstract: An aspect provides a vaccine composition for preventing tuberculosis comprising chorismate mutase. The vaccine composition alone may induce immunity specific to Mycobacterium tuberculosis, and when provided together with an immune adjuvant, the vaccine composition may induce immunity specific to tuberculosis more effectively. Furthermore, when an existing vaccine for tuberculosis is used as a prime and the vaccine composition according to an aspect including chorismite mutase is provided as a booster, the immunity specific to tuberculosis may be induced significantly more effectively.

Abstract: Provided is an immune adjuvant including a polypeptide consisting of an amino acid sequence of SEQ ID NO: 2. The polypeptide is a hepatitis B virus-derived polypeptide, is effective in enhancing immunity through co-administration with vaccines as a single immune adjuvant, and in particular, when coadministered with another immune adjuvant, may exhibit a more remarkable immunity enhancement effect. Furthermore, the polypeptide is a single molecule having only 6 amino acids, is not cytotoxic, and has excellent in vivo stability.

Abstract: Provided is a recombinant BCG employing a pMyong2 vector system to express HIV-1 p24 and a use thereof as a HIV-1 vaccine. rBCG-pMyong2-p24, which is a pMyong2 vector system, was found to induce the upregulation of HIV-1 p24 gag expression in rBCG and infected antigen-presenting cells (APC) and to induce improved p24-specific immune responses in vaccinated mice, compared to rBCG-pAL-p24 in a pAL5000 derived vector system. rBCG-pMyong2-p24 was identified to exhibit a higher p24-specific Ab production level than rSmeg-pMyong2-p24 in the same pMyong2 vector system. Therefore, the recombinant BCG employing rBCG-pMyong2-p24 to express HIV-1 p24 according to the present invention is identified to elicit enhanced immune responses to HIV-1 infection in mouse model systems and thus can be expected to be used as a prime vaccine in the heterologous prime-boost vaccination strategy against HIV-1 infection.

Abstract: Various embodiments of the present invention comprise: a circuit board comprising a first grounding portion and a second grounding portion; a wireless communication circuit arranged in a first area of the circuit board, the wireless communication circuit comprising a first grounding terminal electrically connected to the first grounding portion; an audio codec circuit arranged in a second area of the circuit board, the audio codec circuit comprising a signal input terminal and a second grounding terminal electrically connected to the second grounding portion; and a connector electrically connected to the input terminal, the connector comprising a first pin that can be electrically connected to a signal terminal of a microphone included in an external electronic device and a second pin that can be electrically connected to a grounding terminal of the microphone, the second pin being electrically connectable to the second grounding portion.

Abstract: Provided is a recombinant BCG employing a pMyong2 vector system to express HIV-1 p24 and a use thereof as a HIV-1 vaccine. rBCG-pMyong2-p24, which is a pMyong2 vector system, was found to induce the upregulation of HIV-1 p24 gag expression in rBCG and infected antigen-presenting cells (APC) and to induce improved p24-specific immune responses in vaccinated mice, compared to rBCG-pAL-p24 in a pAL5000 derived vector system. rBCG-pMyong2-p24 was identified to exhibit a higher p24-specific Ab production level than rSmeg-pMyong2-p24 in the same pMyong2 vector system. Therefore, the recombinant BCG employing rBCG-pMyong2-p24 to express HIV-1 p24 according to the present invention is identified to elicit enhanced immune responses to HIV-1 infection in mouse model systems and thus can be expected to be used as a prime vaccine in the heterologous prime-boost vaccination strategy against HIV-1 infection.

Abstract: Various embodiments of the present invention comprise: a circuit board comprising a first grounding portion and a second grounding portion; a wireless communication circuit arranged in a first area of the circuit board, the wireless communication circuit comprising a first grounding terminal electrically connected to the first grounding portion; an audio codec circuit arranged in a second area of the circuit board, the audio codec circuit comprising a signal input terminal and a second grounding terminal electrically connected to the second grounding portion; and a connector electrically connected to the input terminal, the connector comprising a first pin that can be electrically connected to a signal terminal of a microphone included in an external electronic device and a second pin that can be electrically connected to a grounding terminal of the microphone, the second pin being electrically connectable to the second grounding portion.

Abstract: The present disclosure provides an isolated DNA molecule derived from Mycobacteria having a DNA mismatch repair function represented by a nucleic acid sequence as disclosed in SEQ ID NO: 1 or 2. Also provided is a promoter sequence having SEQ ID NO: 3, and a recombinant vector comprising the isolated DNA of the present disclosure and a promoter operatively linked to the DNA molecule. The isolated DNA molecule of the present disclosure is classified as MutS4A and MutS4 and confers cells with resistance to UV and macrophages when transformed into the cells. Further it increases the frequency of homologous recombination and the genetic stability of a heterologous plasmid in cells.

Abstract: An IC card memory includes a header region for storing information about the IC card memory and information about a format, a chapter attribute table (CAT) region for storing information relating to a single chapter, a cluster index table (CIT) region for storing an address of a single cluster index corresponding to a recorded data block, and a data region for storing digital voice data.